These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14597105)

  • 21. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
    Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
    J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients.
    Christophi GP; Christophi JA; Gruber RC; Mihai C; Mejico LJ; Massa PT; Jubelt B
    J Neurol Sci; 2011 Aug; 307(1-2):41-5. PubMed ID: 21658727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA; Yanowitch RN; Reder AT; White DM; Arnason BG
    Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis.
    Salama HH; Kolar OJ; Zang YC; Zhang J
    Mult Scler; 2003 Feb; 9(1):28-31. PubMed ID: 12617264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis.
    Zang YC; Skinner SM; Robinson RR; Li S; Rivera VM; Hutton GJ; Zhang JZ
    Mult Scler; 2004 Oct; 10(5):499-506. PubMed ID: 15471364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
    Mathias A; Perriard G; Canales M; Soneson C; Delorenzi M; Schluep M; Du Pasquier RA
    Mult Scler; 2017 May; 23(6):802-809. PubMed ID: 27503907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response.
    Karni A; Abraham M; Monsonego A; Cai G; Freeman GJ; Hafler D; Khoury SJ; Weiner HL
    J Immunol; 2006 Sep; 177(6):4196-202. PubMed ID: 16951385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.
    Sørensen TL; Sellebjerg F
    Neurology; 2001 Oct; 57(8):1371-6. PubMed ID: 11673573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells.
    Nakae S; Asano M; Horai R; Sakaguchi N; Iwakura Y
    J Immunol; 2001 Jul; 167(1):90-7. PubMed ID: 11418636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses.
    Blazevic V; Trubey CM; Shearer GM
    Hum Immunol; 2000 Sep; 61(9):845-9. PubMed ID: 11053627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.
    González-Oria MC; Márquez-Coello M; Girón-Ortega JA; Argente J; Moya M; Girón-González JA
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):413-422. PubMed ID: 30649665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
    Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
    Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b.
    Iarlori C; Reale M; Lugaresi A; De Luca G; Bonanni L; Di Iorio A; Feliciani C; Conti P; Gambi D
    J Neuroimmunol; 2000 Jul; 107(1):100-7. PubMed ID: 10808056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
    Orima K; Yamazaki K; Aoyagi T; Hara K
    Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells.
    Heinzelmann M; Polk HC; Chernobelsky A; Stites TP; Gordon LE
    Immunopharmacology; 2000 Jul; 48(2):117-28. PubMed ID: 10936509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
    Muraro PA; Leist T; Bielekova B; McFarland HF
    J Neuroimmunol; 2000 Nov; 111(1-2):186-94. PubMed ID: 11063837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human dendritic cell functions by methylprednisolone.
    Vanderheyde N; Verhasselt V; Goldman M; Willems F
    Transplantation; 1999 May; 67(10):1342-7. PubMed ID: 10360588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costimulatory molecules CD80 and CD86 in the rat; tissue distribution and expression by antigen-presenting cells.
    Damoiseaux JG; Yagita H; Okumura K; van Breda Vriesman PJ
    J Leukoc Biol; 1998 Dec; 64(6):803-9. PubMed ID: 9850164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia.
    Vollmer M; Li L; Schmitt A; Greiner J; Reinhardt P; Ringhoffer M; Wiesneth M; Döhner H; Schmitt M
    Br J Haematol; 2003 Mar; 120(6):1000-8. PubMed ID: 12648070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Costimulatory molecule expression on allergen-stimulated PBMC in cedar pollinosis subjects].
    Morikawa H; Baba K
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Mar; 104(3):198-207. PubMed ID: 11305050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.